Telix Pharma Appoints Paul Schaffer Chief Technology Officer

(RTTNews) - Telix Pharmaceuticals Limited (TLX) Monday said that is has appointed Paul Schaffer to the newly created role of Chief Technology Officer, effective today.

Schaffer has been CTO of ARTMS Inc. (ARTMS), which was acquired by Telix in 2024. He was also the Director, Life Science at TRIUMF, Canadas particle accelerator research centre, since 2012.

Christian Behrenbruch, Telix Managing Director and Group Chief Executive Office, said, "Paul has an impressive track record of driving innovation in life sciences technology, including his groundbreaking work in large-scale isotope production. I have first-hand experience of Pauls impressive intellect, ideas and passion through his work at TRIUMF and with ARTMS, so it is a great pleasure to have him join the broader Telix team as we continue to lead radiopharmaceutical innovation."